Hughes Douglas J.
SEC CIK 1710863 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Dir | 134.7K | $150.4K | $503.5K | 9 | 2021-08-27 | 2026-04-07 |
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-09 16:26 | 2026-04-07 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | A - Grant | $0.00 | +13.9K | 134.7K | +11% | $0 |
| M | 2025-12-03 | 2025-12-01 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | S - Sale | $23.24 | -15.0K | 120.8K | -11% | -$348.7K |
| D | 2025-04-03 | 2025-04-01 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | A - Grant | $0.00 | +16.2K | 135.8K | +14% | $0 |
| 2024-12-04 | 2024-12-02 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | S - Sale | $28.54 | -5,425 | 119.6K | -4% | -$154.8K | |
| D | 2024-04-04 | 2024-04-02 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | A - Grant | $0.00 | +11.3K | 125.0K | +10% | $0 |
| D | 2023-04-14 | 2023-04-12 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | A - Grant | $0.00 | +12.5K | 113.8K | +12% | $0 |
| D | 2022-08-19 | 2022-08-17 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | A - Grant | $0.00 | +21.1K | 101.2K | +26% | $0 |
| D | 2022-01-12 | 2022-01-10 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | A - Grant | $0.00 | +21.7K | 80.2K | +37% | $0 |
| 2021-08-30 | 2021-08-27 | IMVT | Immunovant, Inc. | Hughes Douglas J. | Dir | P - Purchase | $8.24 | +18.2K | 58.4K | +45% | +$150.4K |
Purchase Sale Sale after option exercise All abbreviations